Fleury S.A. Market Cap ($2.18 Billion)
Market Cap & Net Worth: Fleury S.A. (FLRY3)
Fleury S.A. market cap. Fleury S.A. (SA:FLRY3) has a market capitalization of $2.18 Billion (R$11.13 Billion) as of October 31, 2026. Listed on the SA stock exchange, this Brazil-based company holds position #5647 globally and #63 in its home market, demonstrating a -26.42% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Fleury S.A.'s stock price R$20.47 by its total outstanding shares 543626208 (543.63 Million).
Fleury S.A. Market Cap History (2015–2026)
Fleury S.A. market cap history from 2015 to 2026. Data shows growth from $506.73 Million to $2.18 Billion (14.03% CAGR). Check FLRY3 live share price for real-time trading data and today's change.
Index Memberships
Fleury S.A. is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
BOVESPA Index
BVSP
|
$560.42 Billion | 0.39% | #38 of 80 |
|
SAO PAULO SE IGCX INDEX
IGCX
|
$575.58 Billion | 0.38% | #41 of 155 |
Weight: Fleury S.A.'s market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Fleury S.A. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Fleury S.A.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Also see Fleury S.A. (FLRY3) cash conversion ratio for how efficiently the company converts equity into cash flow.
Latest Price to Sales (P/S) Ratio
0.19x
Fleury S.A.'s market cap is 0.19 times its annual revenue
Latest Price to Earnings (P/E) Ratio
2.61x
Fleury S.A.'s market cap is 2.61 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $1.31 Billion | $2.10 Billion | $228.75 Million | 0.63x | 5.75x |
| 2017 | $2.25 Billion | $2.38 Billion | $320.62 Million | 0.94x | 7.02x |
| 2018 | $1.56 Billion | $2.66 Billion | $331.58 Million | 0.58x | 4.70x |
| 2019 | $2.53 Billion | $2.91 Billion | $312.32 Million | 0.87x | 8.12x |
| 2020 | $2.30 Billion | $2.97 Billion | $256.96 Million | 0.77x | 8.96x |
| 2021 | $1.60 Billion | $3.87 Billion | $349.93 Million | 0.41x | 4.57x |
| 2022 | $1.48 Billion | $4.46 Billion | $307.91 Million | 0.33x | 4.81x |
| 2023 | $1.86 Billion | $6.47 Billion | $423.76 Million | 0.29x | 4.40x |
| 2024 | $1.29 Billion | $7.68 Billion | $616.17 Million | 0.17x | 2.09x |
| 2025 | $1.60 Billion | $8.29 Billion | $612.83 Million | 0.19x | 2.61x |
Competitor Companies of FLRY3 by Market Capitalization
Companies near Fleury S.A. in the global market cap rankings as of October 31, 2026. See FLRY3 equity financing ratio to understand what proportion of total assets are financed by equity.
Key companies related to Fleury S.A. by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #87 globally with a market cap of $224.59 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #143 globally with a market cap of $164.04 Billion USD.
- Natera Inc (NASDAQ:NTRA): Ranked #480 globally with a market cap of $56.33 Billion USD.
- WuXi AppTec Co Ltd (SHG:603259): Ranked #530 globally with a market cap of $51.40 Billion USD ( CN¥351.23 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #87 | Thermo Fisher Scientific Inc | NYSE:TMO | $224.59 Billion | $697.00 |
| #143 | Danaher Corporation | NYSE:DHR | $164.04 Billion | $232.23 |
| #480 | Natera Inc | NASDAQ:NTRA | $56.33 Billion | $414.30 |
| #530 | WuXi AppTec Co Ltd | SHG:603259 | $51.40 Billion | CN¥142.01 |
Market Capitalization of Fleury S.A. (2015–2026)
Market capitalization of Fleury S.A. from 2015 to today. Between 2015 and today, Fleury S.A.'s market cap moved from $506.73 Million to $ 2.18 Billion, with a yearly change of 14.03%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | R$2.18 Billion | +36.47% |
| 2025 | R$1.60 Billion | +24.28% |
| 2024 | R$1.29 Billion | -30.96% |
| 2023 | R$1.86 Billion | +25.84% |
| 2022 | R$1.48 Billion | -7.25% |
| 2021 | R$1.60 Billion | -30.61% |
| 2020 | R$2.30 Billion | -9.16% |
| 2019 | R$2.53 Billion | +62.73% |
| 2018 | R$1.56 Billion | -30.75% |
| 2017 | R$2.25 Billion | +71.14% |
| 2016 | R$1.31 Billion | +159.38% |
| 2015 | R$506.73 Million | -- |
End of Day Market Cap According to Different Sources
On Oct 31st, 2026 the market cap of Fleury S.A. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $2.18 Billion USD |
| MoneyControl | $2.18 Billion USD |
| MarketWatch | $2.18 Billion USD |
| marketcap.company | $2.18 Billion USD |
| Reuters | $2.18 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Fleury S.A.
Fleury S.A., together with its subsidiaries, engages in the provision of diagnostic imaging, clinical analysis, fertility, and infusions services in Brazil. It operates in two segments, Diagnostic Medicine and Integrated Medicine. The company also provides medical services in the areas of diagnostics, laboratory support, infusions, clinical analyses, health management, healthcare, assistance medi… Read more